Abstract Session
Epidemiology, health policy and outcomes
Karen Costenbader, MD, MPH
Brigham and Women's Hospital/ Harvard Medical School
BOSTON, MA, United States
Disclosure(s): Amgen: Consultant (Ongoing), Grant/Research Support (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing); Cabaletta: Consultant (Ongoing); Eli Lilly: Consultant (Ongoing); Exagen Diagnostics: Grant/Research Support (Ongoing); Gilead: Grant/Research Support (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing), Grant/Research Support (Ongoing); Janssen: Consultant (Ongoing), Grant/Research Support (Ongoing)